Viewing Study NCT05426733


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2025-12-31 @ 5:58 AM
Study NCT ID: NCT05426733
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-12-03
First Post: 2022-06-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
Sponsor: Albireo, an Ipsen Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module